Related Experiment Video
Updated: May 31, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC
M Saxena1, M A Stephens, H Pathak
1Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, Karnataka, India.
Abstract:
Development of multidrug resistance (MDR) is a major deterrent in the effective treatment of metastatic cancers by chemotherapy. Even though MDR and cancer invasiveness have been correlated, the molecular basis of this link remains obscure. We show here that treatment with chemotherapeutic drugs increases the expression of several ATP binding cassette transporters (ABC transporters) associated with MDR, as well as epithelial-mesenchymal transition (EMT) markers, selectively in invasive breast cancer cells, but not in immortalized or non-invasive cells. Interestingly, the mere induction of an EMT in immortalized and non-invasive cell lines increased their expression of ABC transporters, migration, invasion, and drug resistance. Conversely, reversal of EMT in invasive cells by downregulating EMT-inducing transcription factors reduced their expression of ABC transporters, invasion, and rendered them more chemosensitive. Mechanistically, we demonstrate that the promoters of ABC transporters carry several binding sites for EMT-inducing transcription factors, and overexpression of Twist, Snail, and FOXC2 increases the promoter activity of ABC transporters. Furthermore, chromatin immunoprecipitation studies revealed that Twist binds directly to the E-box elements of ABC transporters. Thus, our study identifies EMT inducers as novel regulators of ABC transporters, thereby providing molecular insights into the long-standing association between invasiveness and MDR. Targeting EMT transcription factors could hence serve as novel strategies to curb both metastasis and the associated drug resistance.
Insights
Chemotherapy resistance in metastatic cancers is linked to epithelial-mesenchymal transition (EMT). Inducing EMT increases drug resistance by upregulating ATP binding cassette (ABC) transporters, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Multidrug resistance (MDR) hinders chemotherapy efficacy in metastatic cancers.
- The molecular link between cancer invasiveness and MDR is not well understood.
Purpose of the Study:
- To investigate the relationship between epithelial-mesenchymal transition (EMT) and multidrug resistance (MDR) in breast cancer.
- To elucidate the molecular mechanisms connecting EMT and ATP binding cassette (ABC) transporters.
Main Methods:
- Treatment of invasive, immortalized, and non-invasive breast cancer cells with chemotherapeutic drugs.
- Induction and reversal of EMT in cancer cell lines.
- Analysis of ABC transporter and EMT marker expression.
- Promoter activity assays and chromatin immunoprecipitation to study transcription factor binding.
Main Results:
- Chemotherapy increased ABC transporters and EMT markers in invasive cells.
- EMT induction enhanced ABC transporter expression, migration, invasion, and drug resistance.
- EMT reversal decreased ABC transporters, invasion, and increased chemosensitivity.
- EMT-inducing transcription factors (Twist, Snail, FOXC2) directly regulate ABC transporter promoters.
Conclusions:
- EMT inducers are novel regulators of ABC transporters, explaining the link between invasiveness and MDR.
- Targeting EMT transcription factors may offer strategies to combat both cancer metastasis and drug resistance.
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Treatment Resistant Cancers
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

